For example, Mounjaro contains the active ingredient tirzepatide, a dual agonist that acts on GLP-1 and GIP
"While tirzepatide has known significant weight loss benefits, physicians should be aware of the rare but potentially fatal side effects before initiating treatment," they wrote
Published work in this area has looked at matrix protein expression, fibroblast response and barrier-function markers in skin models
the invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease